Jefferies Maintains VCA Inc to Hold with Price Target $69.00

Brokerage firm Jefferies Maintains its rating on VCA Inc(NASDAQ:WOOF). In a research note issued to the investors, the brokerage major Raises the price-target to $69.00 per share. The shares have been rated Hold. The rating by Jefferies was issued on Jul 28, 2016.

VCA Inc (WOOF) made into the market gainers list on Thursdays trading session with the shares advancing 0.54% or 0.38 points. Due to strong positive momentum, the stock ended at $70.95, which is also near the day’s high of $71.18. The stock began the session at $70.38 and the volume stood at 7,26,184 shares. The 52-week high of the shares is $71.61 and the 52 week low is $44. The company has a current market capitalization of $5,734 M and it has 8,08,23,218 shares in outstanding.

VCA Inc(WOOF) last announced its earnings results on Jul 27, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $653.49M. Analysts had an estimated revenue of $633.90M. Earnings per share were $0.87. Analysts had estimated an EPS of $0.82.

Several Insider Transactions has been reported to the SEC. On Jun 10, 2016, Josh Drake (President, Antech Diagnostics) sold 2,091 shares at $66.05 per share price.Also, On May 24, 2016, Neil Tauber (Senior VP) sold 50,000 shares at $64.17 per share price.On May 20, 2016, Arthur J Antin (COO & Senior VP) sold 200,000 shares at $64.04 per share price, according to the Form-4 filing with the securities and exchange commission.

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *